Jacob Asset Management Of New York LLC Mesoblast LTD Transaction History

Jacob Asset Management Of New York LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$4.17 - $7.09 $718,908 - $1.22 Million	-172,400 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$5.87 - $7.85 $17,610 - $23,550	-3,000 Reduced 1.71%	172,400 $1.04 Million
Q2 2021 Oct 04, 2021	BUY	$6.69 - $9.0 $802,800 - $1.08 Million	120,000 Added 216.61%	175,400 $1.31 Million
Q1 2021 Oct 04, 2021	BUY	$8.26 - $11.4 $284,970 - $393,300	34,500 Added 165.07%	55,400 $458,000
Q4 2020 Oct 04, 2021	BUY	$8.21 - $18.59 $171,589 - $388,531	20,900 New	20,900 $177,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.54B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Jacob Asset Management Of New York LLC, based on Form 13F filings with the SEC.

Stay updated on Jacob Asset Management Of New York LLC with notifications on news.